| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | selenide, water dikinase activity | 3.76e-05 | 2 | 123 | 2 | GO:0004756 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, paired acceptors | 3.76e-05 | 2 | 123 | 2 | GO:0016781 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 4.31e-05 | 32 | 123 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | UBR1 TRIM31 TRIM34 HUWE1 TTC3 TRIM64C FBXL21P FBXO2 GGT5 RNFT2 TRIM36 TRIM44 | 1.11e-04 | 532 | 123 | 12 | GO:0016755 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | UBR1 TRIM31 TRIM34 HUWE1 TTC3 TRIM64C FBXL21P FBXO2 RNFT2 TRIM36 TRIM44 | 1.67e-04 | 473 | 123 | 11 | GO:0004842 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | UBR1 TRIM31 TRIM34 HUWE1 TTC3 TRIM64C FBXL21P FBXO2 RNFT2 TRIM36 TRIM44 | 3.29e-04 | 512 | 123 | 11 | GO:0019787 |
| GeneOntologyBiologicalProcess | dADP metabolic process | 3.47e-05 | 2 | 122 | 2 | GO:0046056 | |
| GeneOntologyBiologicalProcess | selenocysteine biosynthetic process | 3.47e-05 | 2 | 122 | 2 | GO:0016260 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 4.11e-05 | 12 | 122 | 3 | GO:0031074 | |
| Domain | ARM-type_fold | KPNA5 USP34 SMG1 INTS1 XPO4 PSMD1 RICTOR HUWE1 FOCAD PPP2R5C MROH1 ARMC5 TAF6 UNC79 KPNB1 | 4.75e-09 | 339 | 120 | 15 | IPR016024 |
| Domain | ARM-like | KPNA5 SMG1 XPO4 PSMD1 RICTOR HUWE1 PPP2R5C MROH1 ARMC5 TAF6 KPNB1 | 1.36e-06 | 270 | 120 | 11 | IPR011989 |
| Domain | - | 1.34e-05 | 222 | 120 | 9 | 1.25.10.10 | |
| Domain | SPS/SelD | 4.09e-05 | 2 | 120 | 2 | IPR004536 | |
| Domain | - | 1.22e-04 | 3 | 120 | 2 | 3.90.650.10 | |
| Domain | - | 2.44e-04 | 4 | 120 | 2 | 3.30.1330.10 | |
| Domain | AIRS_C | 2.44e-04 | 4 | 120 | 2 | PF02769 | |
| Domain | AIRS | 2.44e-04 | 4 | 120 | 2 | PF00586 | |
| Domain | PurM-like_N | 2.44e-04 | 4 | 120 | 2 | IPR016188 | |
| Domain | AIR_synth_C_dom | 2.44e-04 | 4 | 120 | 2 | IPR010918 | |
| Domain | Znf_RING | 2.58e-04 | 326 | 120 | 9 | IPR001841 | |
| Domain | P-loop_NTPase | RAN MYO7B MYO9A DYNC2H1 HS6ST2 DDX60 DAPK1 PSTK RERGL AK5 CHTF18 RAB40C DDX60L MYO15A NLRP8 | 3.52e-04 | 848 | 120 | 15 | IPR027417 |
| Domain | ZF_RING_1 | 5.87e-04 | 291 | 120 | 8 | PS00518 | |
| Domain | zf-C3HC4 | 5.98e-04 | 223 | 120 | 7 | PF00097 | |
| Domain | - | UBR1 RAPSN VPS8 TRIM31 TRIM34 TTC3 NSD3 RNFT2 ZFYVE26 TRIM36 | 6.42e-04 | 449 | 120 | 10 | 3.30.40.10 |
| Domain | ZF_RING_2 | 6.86e-04 | 298 | 120 | 8 | PS50089 | |
| Domain | Znf_RING/FYVE/PHD | UBR1 RAPSN VPS8 TRIM31 TRIM34 TTC3 NSD3 RNFT2 ZFYVE26 TRIM36 | 7.61e-04 | 459 | 120 | 10 | IPR013083 |
| Domain | RING | 7.98e-04 | 305 | 120 | 8 | SM00184 | |
| Domain | BBOX | 1.02e-03 | 69 | 120 | 4 | SM00336 | |
| Domain | - | 1.13e-03 | 71 | 120 | 4 | 4.10.45.10 | |
| Domain | zf-B_box | 1.19e-03 | 72 | 120 | 4 | PF00643 | |
| Domain | MYTH4 | 1.43e-03 | 9 | 120 | 2 | PS51016 | |
| Domain | MyTH4 | 1.43e-03 | 9 | 120 | 2 | SM00139 | |
| Domain | MyTH4_dom | 1.43e-03 | 9 | 120 | 2 | IPR000857 | |
| Domain | MyTH4 | 1.43e-03 | 9 | 120 | 2 | PF00784 | |
| Domain | ZF_BBOX | 1.76e-03 | 80 | 120 | 4 | PS50119 | |
| Domain | Znf_B-box | 1.84e-03 | 81 | 120 | 4 | IPR000315 | |
| Domain | Myosin_head_motor_dom | 1.85e-03 | 38 | 120 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.85e-03 | 38 | 120 | 3 | PS51456 | |
| Domain | Myosin_head | 1.85e-03 | 38 | 120 | 3 | PF00063 | |
| Domain | MYSc | 1.85e-03 | 38 | 120 | 3 | SM00242 | |
| Domain | ARM | 2.15e-03 | 40 | 120 | 3 | SM00185 | |
| Domain | SH3_2 | 2.29e-03 | 86 | 120 | 4 | PF07653 | |
| Domain | SH3_2 | 2.29e-03 | 86 | 120 | 4 | IPR011511 | |
| Domain | - | 2.59e-03 | 12 | 120 | 2 | 3.40.50.1010 | |
| Domain | SH3 | 2.73e-03 | 216 | 120 | 6 | SM00326 | |
| Domain | SH3 | 2.73e-03 | 216 | 120 | 6 | PS50002 | |
| Domain | SH3_domain | 2.99e-03 | 220 | 120 | 6 | IPR001452 | |
| Domain | - | RAN MYO7B DYNC2H1 DDX60 PSTK RERGL AK5 CHTF18 RAB40C DDX60L MYO15A NLRP8 | 3.09e-03 | 746 | 120 | 12 | 3.40.50.300 |
| Domain | FERM_M | 3.21e-03 | 46 | 120 | 3 | PF00373 | |
| Domain | Armadillo | 3.41e-03 | 47 | 120 | 3 | IPR000225 | |
| Domain | PIN_domain-like | 3.54e-03 | 14 | 120 | 2 | IPR029060 | |
| Domain | FERM_central | 3.84e-03 | 49 | 120 | 3 | IPR019748 | |
| Domain | FERM_domain | 3.84e-03 | 49 | 120 | 3 | IPR000299 | |
| Domain | FERM_1 | 4.07e-03 | 50 | 120 | 3 | PS00660 | |
| Domain | FERM_2 | 4.07e-03 | 50 | 120 | 3 | PS00661 | |
| Domain | FERM_3 | 4.07e-03 | 50 | 120 | 3 | PS50057 | |
| Domain | Band_41_domain | 4.07e-03 | 50 | 120 | 3 | IPR019749 | |
| Domain | B41 | 4.07e-03 | 50 | 120 | 3 | SM00295 | |
| Domain | Znf_C3HC4_RING-type | 5.08e-03 | 172 | 120 | 5 | IPR018957 | |
| Domain | HEAT_type_2 | 5.23e-03 | 17 | 120 | 2 | IPR021133 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 11212352 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 BICRA INTS1 MYOM3 HUWE1 TTC3 GADD45A NSD3 FOCAD GAS2L1 SEPHS2 MROH1 NAPRT DIP2C ZFYVE26 ARHGAP33 | 1.90e-06 | 1105 | 123 | 16 | 35748872 |
| Pubmed | Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. | 5.09e-06 | 10 | 123 | 3 | 10944119 | |
| Pubmed | HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr. | 6.98e-06 | 11 | 123 | 3 | 9562972 | |
| Pubmed | Ribosomal protein L12 uses a distinct nuclear import pathway mediated by importin 11. | 6.98e-06 | 11 | 123 | 3 | 11809816 | |
| Pubmed | 9.28e-06 | 12 | 123 | 3 | 31732746 | ||
| Pubmed | Sequence and characterization of cytoplasmic nuclear protein import factor p97. | 1.24e-05 | 2 | 123 | 2 | 7615630 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 10477765 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 15328371 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 18708071 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 15534230 | ||
| Pubmed | Successful COG8 and PDF overlap is mediated by alterations in splicing and polyadenylation signals. | 1.24e-05 | 2 | 123 | 2 | 21805148 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9135132 | ||
| Pubmed | Structural view of the Ran-Importin beta interaction at 2.3 A resolution. | 1.24e-05 | 2 | 123 | 2 | 10367892 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8692944 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8576188 | ||
| Pubmed | The role of RanGTP gradient in vertebrate oocyte maturation. | 1.24e-05 | 2 | 123 | 2 | 21630149 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16675143 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 37694145 | ||
| Pubmed | [The nuclear import of Newcastle disease virus matrix protein depends on KPNB1 and Ran protein]. | 1.24e-05 | 2 | 123 | 2 | 29746765 | |
| Pubmed | Importin-β modulates the permeability of the nuclear pore complex in a Ran-dependent manner. | 1.24e-05 | 2 | 123 | 2 | 25748139 | |
| Pubmed | 1.36e-05 | 41 | 123 | 4 | 11331580 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC37A1 PDE9A MYO9A BICRA SLC22A23 FRMPD1 PSMD1 CCND1 HUWE1 TTC3 HPS3 DFFB SMG7 GUCY1A1 NETO1 RBM6 DIP2C | 2.02e-05 | 1489 | 123 | 17 | 28611215 |
| Pubmed | UBR1 SMG1 ARHGAP23 RICTOR EIF2D WASHC5 CHTF18 DSTYK ARMC5 DBR1 GARRE1 | 2.08e-05 | 650 | 123 | 11 | 38777146 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 RAN FAM120B WARS1 ARHGAP23 MYO9A PSMD1 RICTOR HUWE1 SSRP1 EIF2D RNH1 WASHC5 CHTF18 DDX60L KPNB1 | 2.38e-05 | 1353 | 123 | 16 | 29467282 |
| Pubmed | Armc5 deletion causes developmental defects and compromises T-cell immune responses. | 2.83e-05 | 17 | 123 | 3 | 28169274 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 7627554 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 9136771 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 27306458 | ||
| Pubmed | S1PR3 Mediates Itch and Pain via Distinct TRP Channel-Dependent Pathways. | 3.71e-05 | 3 | 123 | 2 | 30082422 | |
| Pubmed | Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsyn. | 3.71e-05 | 3 | 123 | 2 | 10320756 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 10037787 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 10934257 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 28835592 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 10397761 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 18845677 | ||
| Pubmed | TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo. | 3.71e-05 | 3 | 123 | 2 | 21981454 | |
| Pubmed | Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1. | 3.71e-05 | 3 | 123 | 2 | 21625522 | |
| Pubmed | Identification of different roles for RanGDP and RanGTP in nuclear protein import. | 3.71e-05 | 3 | 123 | 2 | 8896452 | |
| Pubmed | Different binding domains for Ran-GTP and Ran-GDP/RanBP1 on nuclear import factor p97. | 3.71e-05 | 3 | 123 | 2 | 9045717 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 31653923 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 28414460 | ||
| Pubmed | RanBP1 stabilizes the interaction of Ran with p97 nuclear protein import. | 7.41e-05 | 4 | 123 | 2 | 8909533 | |
| Pubmed | Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. | 7.41e-05 | 4 | 123 | 2 | 9323134 | |
| Pubmed | The Inner Nuclear Membrane Protein Nemp1 Is a New Type of RanGTP-Binding Protein in Eukaryotes. | 7.41e-05 | 4 | 123 | 2 | 25946333 | |
| Pubmed | 7.41e-05 | 4 | 123 | 2 | 17209048 | ||
| Pubmed | 7.41e-05 | 4 | 123 | 2 | 20658144 | ||
| Pubmed | Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. | 7.41e-05 | 4 | 123 | 2 | 11323662 | |
| Pubmed | 7.41e-05 | 4 | 123 | 2 | 17938174 | ||
| Pubmed | Characterization of the nuclear import pathway for BLM protein. | 7.41e-05 | 4 | 123 | 2 | 29017749 | |
| Pubmed | Facilitated nucleocytoplasmic shuttling of the Ran binding protein RanBP1. | 7.41e-05 | 4 | 123 | 2 | 10779340 | |
| Pubmed | 1.06e-04 | 26 | 123 | 3 | 20301347 | ||
| Pubmed | Muscle-like nicotinic receptor accessory molecules in sensory hair cells of the inner ear. | 1.23e-04 | 5 | 123 | 2 | 18420419 | |
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 10209022 | ||
| Pubmed | ColQ controls postsynaptic differentiation at the neuromuscular junction. | 1.23e-04 | 5 | 123 | 2 | 20053883 | |
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 9214382 | ||
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 14600264 | ||
| Pubmed | RanGTP aids anaphase entry through Ubr5-mediated protein turnover. | 1.23e-04 | 5 | 123 | 2 | 26438829 | |
| Pubmed | The mechanism of nuclear export of Smad3 involves exportin 4 and Ran. | 1.23e-04 | 5 | 123 | 2 | 16449645 | |
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 15929992 | ||
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 16807365 | ||
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 9102465 | ||
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 9885975 | ||
| Pubmed | Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression. | 1.23e-04 | 5 | 123 | 2 | 12101123 | |
| Pubmed | RanGTP and CLASP1 cooperate to position the mitotic spindle. | 1.23e-04 | 5 | 123 | 2 | 23783028 | |
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 23444224 | ||
| Pubmed | 1.23e-04 | 5 | 123 | 2 | 9405152 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RAN WARS1 DYNC2H1 PSMD1 DAPK1 RICTOR MUC5B HUWE1 MYO15A UNC79 KPNB1 | 1.43e-04 | 807 | 123 | 11 | 30575818 |
| Pubmed | 1.55e-04 | 322 | 123 | 7 | 26514267 | ||
| Pubmed | Inhibition of nuclear import by the proapoptotic protein CC3. | 1.84e-04 | 6 | 123 | 2 | 15282309 | |
| Pubmed | 1.84e-04 | 6 | 123 | 2 | 12176322 | ||
| Pubmed | 1.84e-04 | 6 | 123 | 2 | 26491019 | ||
| Pubmed | Motoneuron survival is enhanced in the absence of neuromuscular junction formation in embryos. | 1.84e-04 | 6 | 123 | 2 | 11312299 | |
| Pubmed | Nup153 is an M9-containing mobile nucleoporin with a novel Ran-binding domain. | 1.84e-04 | 6 | 123 | 2 | 10202161 | |
| Pubmed | Phosphorylation of Crm1 by CDK1-cyclin-B promotes Ran-dependent mitotic spindle assembly. | 1.84e-04 | 6 | 123 | 2 | 23729730 | |
| Pubmed | 2.42e-04 | 85 | 123 | 4 | 19028597 | ||
| Pubmed | 2.58e-04 | 7 | 123 | 2 | 14636577 | ||
| Pubmed | 2.58e-04 | 7 | 123 | 2 | 25042397 | ||
| Pubmed | Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction. | 2.58e-04 | 7 | 123 | 2 | 17640526 | |
| Pubmed | Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. | 2.58e-04 | 7 | 123 | 2 | 17916692 | |
| Pubmed | The interaction of Epac1 and Ran promotes Rap1 activation at the nuclear envelope. | 2.58e-04 | 7 | 123 | 2 | 20547757 | |
| Pubmed | Importin-11, a nuclear import receptor for the ubiquitin-conjugating enzyme, UbcM2. | 2.58e-04 | 7 | 123 | 2 | 11032817 | |
| Pubmed | An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A. | 3.43e-04 | 8 | 123 | 2 | 20818336 | |
| Pubmed | 3.43e-04 | 8 | 123 | 2 | 18187047 | ||
| Pubmed | Essential roles of the acetylcholine receptor gamma-subunit in neuromuscular synaptic patterning. | 3.43e-04 | 8 | 123 | 2 | 18434415 | |
| Pubmed | 3.43e-04 | 8 | 123 | 2 | 8653787 | ||
| Pubmed | Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. | 3.43e-04 | 8 | 123 | 2 | 10655525 | |
| Pubmed | Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm. | 3.43e-04 | 8 | 123 | 2 | 20015032 | |
| Pubmed | Aberrant development of motor axons and neuromuscular synapses in MyoD-null mice. | 3.43e-04 | 8 | 123 | 2 | 12832540 | |
| Pubmed | XPO4 PSMD1 RICTOR HUWE1 NSD3 PPP2R5C SMG7 WASHC5 SLC39A6 TRIM36 KPNB1 ILKAP | 3.56e-04 | 1049 | 123 | 12 | 27880917 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 3.57e-04 | 170 | 123 | 5 | 23314748 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 3.70e-04 | 95 | 123 | 4 | 29643511 | |
| Pubmed | The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. | 4.39e-04 | 9 | 123 | 2 | 16488880 | |
| Pubmed | 4.39e-04 | 9 | 123 | 2 | 10525473 | ||
| Pubmed | 4.39e-04 | 9 | 123 | 2 | 11389849 | ||
| Pubmed | Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. | 4.39e-04 | 9 | 123 | 2 | 9463369 | |
| Pubmed | 4.39e-04 | 9 | 123 | 2 | 21326825 | ||
| Pubmed | 4.39e-04 | 9 | 123 | 2 | 12414950 | ||
| Pubmed | 4.39e-04 | 9 | 123 | 2 | 11035935 | ||
| Pubmed | 4.39e-04 | 9 | 123 | 2 | 9275210 | ||
| Interaction | NPTN interactions | SMG1 DYNC2H1 INTS1 XPO4 HUWE1 COG8 FOCAD MROH1 DSTYK ZFYVE26 | 6.99e-06 | 278 | 121 | 10 | int:NPTN |
| Cytoband | 1q25 | 4.66e-05 | 26 | 123 | 3 | 1q25 | |
| GeneFamily | Ring finger proteins | 3.19e-05 | 275 | 81 | 8 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 6.73e-05 | 95 | 81 | 5 | 59 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.40e-04 | 43 | 81 | 3 | 409 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.46e-03 | 50 | 81 | 3 | 1293 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.90e-03 | 18 | 81 | 2 | 596 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-07 | 157 | 123 | 7 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-06 | 161 | 123 | 6 | 8937f6b92cb2a93ea8c4780d9200a518c3112e53 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 182 | 123 | 6 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | facs-Limb_Muscle|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 189 | 123 | 6 | 21ec43859d21ffc565acbe36489da1d2d0f9877d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 193 | 123 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 123 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 123 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.97e-05 | 200 | 123 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 4.99e-05 | 18 | 119 | 3 | OBA_2045065 | |
| Disease | Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [2] measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0022103 | |
| Disease | Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0022114 | |
| Disease | 2-arachidonoylglycerol (20:4) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800182 | |
| Disease | 2-linoleoyl-GPC (18:2) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800239 | |
| Disease | 1-dihomo-linoleoyl-GPC (20:2) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800236 | |
| Disease | docosapentaenoate (n6 DPA; 22:5n6) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800249 | |
| Disease | 1-linoleoyl-2-docosahexaenoyl-GPC (18:2/22:6) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0022080 | |
| Disease | 1-margaroyl-2-arachidonoyl-GPC (17:0/20:4) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0022081 | |
| Disease | 1-arachidoyl-2-arachidonoyl-GPC (20:0/20:4) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0022079 | |
| Disease | phosphatidylcholine (O-18:1/20:4, O-16:0/22:5n3) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800553 | |
| Disease | arachidonate 20:4n6-to-dihomo-linolenate 20:3n3 or n6 ratio | 9.63e-05 | 4 | 119 | 2 | EFO_0021517 | |
| Disease | fatty acid measurement, linolenic acid measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0005110, EFO_0006811 | |
| Disease | phosphatidylcholine acyl-alkyl C38:5 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801299 | |
| Disease | phosphatidylcholine acyl-alkyl C36:4 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801292 | |
| Disease | phosphatidylcholine acyl-alkyl C36:2 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801290 | |
| Disease | phosphatidylcholine diacyl C38:5 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801267 | |
| Disease | phosphatidylcholine diacyl C38:4 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801266 | |
| Disease | phosphatidylcholine diacyl C36:4 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801260 | |
| Disease | phosphatidylcholine diacyl C40:6 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801274 | |
| Disease | phosphatidylcholine diacyl C36:3 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801259 | |
| Disease | phosphatidylcholine diacyl C34:4 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801255 | |
| Disease | level of Phosphatidylcholine (O-16:0_22:5) in blood serum | 9.63e-05 | 4 | 119 | 2 | OBA_2045117 | |
| Disease | sphingomyeline C16:1 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0801318 | |
| Disease | 1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800483 | |
| Disease | eicosapentaenoylcholine measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800482 | |
| Disease | comprehensive strength index, muscle measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0004515, EFO_0004979 | |
| Disease | 1-stearoyl-2-adrenoyl-GPC (18:0/22:4) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800459 | |
| Disease | 1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800458 | |
| Disease | phosphatidylcholine (18:0/20:5, 16:0/22:5n6) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800468 | |
| Disease | 1-stearoyl-2-meadoyl-GPC (18:0/20:3n9) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800463 | |
| Disease | 1-pentadecanoyl-2-arachidonoyl-GPC (15:0/20:4) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800446 | |
| Disease | 1-palmitoyl-2-alpha-linolenoyl-GPC (16:0/18:3n3) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800442 | |
| Disease | 1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800408 | |
| Disease | Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency | 9.63e-05 | 4 | 119 | 2 | C1837092 | |
| Disease | phosphatidylcholine 33:2 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0021470 | |
| Disease | phosphatidylcholine 33:1 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0021469 | |
| Disease | 1,2-dilinoleoyl-GPC (18:2/18:2) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800388 | |
| Disease | 1-eicosapentaenoyl-GPC (20:5) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800355 | |
| Disease | 1-(1-enyl-stearoyl)-GPC (P-18:0) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800325 | |
| Disease | 1-(1-enyl-oleoyl)-GPC (P-18:1) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800324 | |
| Disease | 1-lignoceroyl-GPC (24:0) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800322 | |
| Disease | 1-adrenoyl-GPC (22:4) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800321 | |
| Disease | 2-arachidonoyl-GPC (20:4) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800237 | |
| Disease | 1-arachidonoyl-GPC (20:4n6) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800234 | |
| Disease | 1-linoleoyl-GPC (18:2) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800223 | |
| Disease | fatty acid measurement, docosapentaenoic acid measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0005110, EFO_0006809 | |
| Disease | phosphatidylcholine acyl-alkyl C36:5 measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0801293 | |
| Disease | sphingomyeline C18:1 measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0801320 | |
| Disease | 1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800484 | |
| Disease | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800467 | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800415 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800407 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800417 | |
| Disease | 1-linolenoyl-GPE (18:3) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800365 | |
| Disease | 1-(1-enyl-stearoyl)-GPE (P-18:0) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800335 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.36e-04 | 303 | 119 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | Sphingomyelin (d18:1/20:1, d18:2/20:0) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0022110 | |
| Disease | Sphingomyelin (d18:1/18:1, d18:2/18:0) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0022108 | |
| Disease | 1-stearoyl-GPC (18:0) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800217 | |
| Disease | 1-arachidonylglycerol (20:4) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800224 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0801920 | |
| Disease | arachidonic acid measurement, fatty acid measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0005110, EFO_0006808 | |
| Disease | adrenate 22:4n6 measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0021062 | |
| Disease | 1-arachidonoylglycerophosphocholine measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0021076 | |
| Disease | dihomo-linolenate 20:3n3 or n6 measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0021046 | |
| Disease | docosapentaenoate n3 DPA; 22:5n3 measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0021048 | |
| Disease | 1-linoleoylglycerophosphoethanolamine measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0021084 | |
| Disease | level of Phosphatidylcholine (18:2_0:0) in blood serum | 2.39e-04 | 6 | 119 | 2 | OBA_2045105 | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800394 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800390 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:2) in blood serum | 2.39e-04 | 6 | 119 | 2 | OBA_2045134 | |
| Disease | level of Phosphatidylcholine (O-16:0_18:2) in blood serum | 2.39e-04 | 6 | 119 | 2 | OBA_2045114 | |
| Disease | arachidonoylcholine measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800478 | |
| Disease | 1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800471 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800434 | |
| Disease | level of Phosphatidylinositol (18:1_18:2) in blood serum | 2.39e-04 | 6 | 119 | 2 | OBA_2045160 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800444 | |
| Disease | 1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800426 | |
| Disease | 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800404 | |
| Disease | lysophosphatidylcholine 18:3 measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0021454 | |
| Disease | 1-docosapentaenoyl-GPC (22:5n3) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800298 | |
| Disease | 1-(1-enyl-palmitoyl)-GPC (P-16:0) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800323 | |
| Disease | level of Phosphatidylcholine (18:0_20:2) in blood serum | 2.39e-04 | 6 | 119 | 2 | OBA_2045092 | |
| Disease | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0020014 | |
| Disease | X-24870 measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0022143 | |
| Disease | 1,2-dipalmitoyl-GPC (16:0/16:0) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800189 | |
| Disease | 1-arachidonoyl-GPI (20:4) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800256 | |
| Disease | 1-linoleoyl-GPI (18:2) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800266 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800609 | |
| Disease | eicosapentaenoate (EPA; 20:5n3) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800616 | |
| Disease | level of Sterol ester (27:1/22:6) in blood serum | 3.34e-04 | 7 | 119 | 2 | OBA_2045201 | |
| Disease | arachidonate 20:4n6 measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0021063 | |
| Disease | 1-eicosatrienoylglycerophosphocholine measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0021081 | |
| Disease | level of Phosphatidylcholine (18:2_20:3) in blood serum | 3.34e-04 | 7 | 119 | 2 | OBA_2045108 | |
| Disease | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800391 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:1) in blood serum | 3.34e-04 | 7 | 119 | 2 | OBA_2045133 | |
| Disease | level of Phosphatidylcholine (O-18:2_20:4) in blood serum | 3.34e-04 | 7 | 119 | 2 | OBA_2045135 | |
| Disease | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800470 | |
| Disease | level of Sphingomyelin (d36:2) in blood serum | 3.34e-04 | 7 | 119 | 2 | OBA_2045177 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVIPLFLPQCRECNA | 101 | P40394 | |
| IICICNDQFAPSLRQ | 486 | Q8WVB6 | |
| PIVVALCEANCNLDI | 591 | P53355 | |
| NLVRLDPILCDCILE | 431 | P41214 | |
| LRQCCVLFDFVSDPL | 46 | Q13362 | |
| QPLVRAVCLLCREAI | 346 | Q96C12 | |
| PDCLRACQEQIEALL | 241 | P24385 | |
| CQEVLRKGCLRFQLP | 26 | O76075 | |
| NRLQALPALCLCVLV | 6 | P55056 | |
| NAECRDFVLNCEILP | 201 | O15131 | |
| VCPVLADIECRAAQL | 1371 | Q9HC84 | |
| RDLVRVCENIPIVLC | 106 | P62826 | |
| PNRVFSLQDLCCRAI | 186 | Q96S21 | |
| RECIYIIEAAPRQCI | 66 | Q8TDF5 | |
| DRPLQALCLLCFADI | 241 | Q13702 | |
| LENPVIIDIFCVCDS | 306 | Q8HWS3 | |
| PDAIILCVRQICAVI | 156 | P57723 | |
| SLDVLPVQCLCEFLL | 901 | Q8N201 | |
| QELPCDLVCQRLVAT | 181 | Q6ZVK8 | |
| EDQICTPDLVVFLAC | 231 | Q9Y6K8 | |
| PDCTLQILELENCLF | 951 | Q86W28 | |
| GILRILDDQCCFPQA | 1656 | Q9UKN7 | |
| LCCLALLPQEVLDIQ | 276 | O00221 | |
| NCQVLITVPACFEIL | 856 | Q8IY21 | |
| NCQVLITVPECFEIL | 836 | Q5H9U9 | |
| ALPAAELVQACRLVC | 61 | Q9UK22 | |
| LLKPELQVCVFCRNN | 206 | Q8WY41 | |
| CAVAFQILAEPECNI | 386 | O76083 | |
| FIVNDELPNCILCGA | 281 | P31512 | |
| QCPVVRFICRLDQTL | 376 | Q8N2G8 | |
| ETAQQICEDLRLCIP | 126 | P22749 | |
| NILVAFNDLRLCCPV | 441 | Q96MW5 | |
| FNDLRLCCPVALAQD | 446 | Q96MW5 | |
| RIDILINCAAGNFLC | 106 | Q9NUI1 | |
| QLLARTCCELQAEPL | 136 | A6NHZ5 | |
| LVINCLDCPENVFLR | 406 | Q96F86 | |
| CDSCFQVIFPQDVLR | 421 | Q6ZWE6 | |
| QVLALELPEALCREC | 121 | Q9HBH1 | |
| QLSLELCRQLPCYDE | 626 | Q8NDA8 | |
| NPDIFTEVANCCIRI | 1881 | Q7Z6Z7 | |
| ACIAIICELALQNPE | 186 | Q6R327 | |
| QIVDCLPCILILGQD | 106 | Q6XUX3 | |
| LQVDLPCFICLKRLN | 506 | Q14392 | |
| PCFICLKRLNLAENR | 511 | Q14392 | |
| VQNAIRDLPCTCEFV | 176 | Q6GPH6 | |
| QDVPQVLRCCSEFIE | 326 | O14559 | |
| VCFLFLIEHPNDVRC | 236 | P57057 | |
| PLLCNCLEINNFLDD | 31 | Q8NCM8 | |
| LLDCICPEVRLFQVS | 31 | Q9H5Z6 | |
| PLATELRCQCLQTLQ | 36 | P19875 | |
| LVREILGRCTCPDQF | 211 | Q99501 | |
| LCLLDLAQRANPQCQ | 656 | Q5SYB0 | |
| FCCENDINILRVSNP | 81 | P24522 | |
| PCIQIQLQREICDFG | 501 | O15063 | |
| RCQLTPNDRFILLAC | 311 | Q9H0C8 | |
| LQCELYPSREVAICL | 1166 | Q9Y2E4 | |
| GIILNNELLDLCERC | 421 | P36269 | |
| DLCRALQSNIIPFCD | 676 | Q14974 | |
| CDSIEQPLLLIQEIC | 366 | A6NNW6 | |
| LVRNIQLEQPCECRV | 246 | Q96MM7 | |
| VDLLLCCGDFQAVRN | 31 | Q9UK59 | |
| GRCLLDVICDPQALN | 6 | Q9NZM4 | |
| VPARLCCIFLLQQIG | 421 | Q9Y267 | |
| QVGICLLLVELCERF | 41 | A6NIM6 | |
| ILFLIDVACRVQACP | 261 | Q99500 | |
| STLRQQLFIVCEPCQ | 661 | Q8TDX9 | |
| LFCLSLNNPIRRACI | 106 | Q01668 | |
| LILQRCLEEEYLRPC | 181 | Q8N4L8 | |
| ELCNVNLGFLLPRSC | 151 | Q56UN5 | |
| ILEQQILQLCCDIVP | 216 | Q5VW36 | |
| QAVESPFQALCCLLI | 711 | Q96EK7 | |
| QVTRILPCLLDGDCF | 441 | O15259 | |
| EQRIPTLNEYCVVCD | 276 | Q2NL67 | |
| NCPRLIELVVCANDL | 336 | Q9UKT6 | |
| ICQAEFREPLILLCQ | 386 | Q96EX2 | |
| FREPLILLCQHVFCE | 391 | Q96EX2 | |
| IFRDRTDIQCLIPCA | 296 | P23381 | |
| CIVSRQLCLRPDVDN | 311 | P49848 | |
| ACLLCRRQFPNKEVL | 956 | P78332 | |
| RICELYLNEQIGPCL | 431 | A5PLK6 | |
| FVNKLQEEVICPICL | 6 | Q9BZY9 | |
| LLNVQEEVTCPICLE | 6 | Q9BYJ4 | |
| NIERELICPACKELF | 26 | Q9NQ86 | |
| QEDRQLICVLCPVIG | 191 | Q96DX7 | |
| CQLVQVALGCFALRL | 146 | Q8IUW3 | |
| CLERKQLNLEIYDPC | 46 | Q9H628 | |
| QCIDILLERCPEAVI | 906 | Q969F9 | |
| CIICILLLPESRDQN | 611 | A1A5C7 | |
| LQELCTVFNVDLPCR | 106 | Q92540 | |
| PDDLLQRCVDVCRVQ | 791 | Q96Q15 | |
| PDFINVCQCLIFLDD | 211 | Q99460 | |
| ICLPREQAARFCAEI | 326 | P49903 | |
| PCITEQFIELLCQFN | 1026 | Q8N3P4 | |
| DRVLKCCLQHQELFP | 486 | Q5T5J6 | |
| CPAIINQIDARSCLI | 291 | Q13433 | |
| CCELLLFNRAQLGIA | 296 | Q9Y566 | |
| GDAICIFRELQCLTP | 196 | Q08945 | |
| ICLPREQAARFCSEI | 376 | Q99611 | |
| CFLFCTGEIRQEIPN | 1021 | O75762 | |
| LDNIPKLLNCLRDCN | 356 | Q12768 | |
| VCQLCLEALTPLAEQ | 1021 | Q9C0E2 | |
| NQRVPLIVAACCRIV | 916 | Q9P227 | |
| QLFLDCPLETCLQRN | 176 | Q8IV42 | |
| CELAQALRDGVLLCQ | 31 | P15498 | |
| FRQIFCQACLREEPD | 331 | Q8IWV7 | |
| LLGCPRFVVIDNCIA | 1156 | P53804 | |
| LLQQCQVVRLDDCGL | 26 | P13489 | |
| QLLCEGLLDPQCRLE | 131 | P13489 | |
| EPLLRLCLQQGQLCE | 471 | Q6XQN6 | |
| CVQEILQRCPEVDLL | 856 | Q9BQI6 | |
| QIQVADLSEIPRCNC | 1086 | Q9BZ95 | |
| LGICDAALCRQVQLL | 191 | Q53HV7 | |
| CVQCTPVQLEILRRA | 91 | Q2VWA4 | |
| YNVCADCPENIRLIV | 2806 | Q70CQ2 | |
| LRVFQNELICCICVN | 6 | A6NLI5 | |
| IRICCDELNLLVPFC | 416 | Q9UL49 | |
| ALVVCPNLLRCGQDI | 56 | Q68DK2 | |
| SCPINCQLLEALVAL | 1631 | O60293 | |
| PLQLQCCQRLVELCK | 806 | Q6ZT98 | |
| LCYQLACELLERLAP | 866 | Q9P2D8 | |
| VDLLCSIFPCEVAQQ | 451 | Q02108 | |
| LLQLPQVVEVCCHFL | 291 | Q9NR64 | |
| ICVRLCEQGINPEAL | 46 | Q08AG7 | |
| PLSCAEQLCIARQVA | 696 | O15146 | |
| ILRPSLRDEIYCQIC | 1101 | Q6PIF6 | |
| ANALAIVFAPCILRC | 2206 | B2RTY4 | |
| PLNVRCLDVNRDCLI | 376 | Q5VTT5 |